Drug Type Small molecule drug |
Synonyms BCR 0005, BCR0005 |
Target |
Action inhibitors |
Mechanism PTP1B inhibitors(Protein-tyrosine phosphatase 1B inhibitors), PTPN2 inhibitors(Tyrosine-protein phosphatase non-receptor type 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Discovery | China | 01 Nov 2024 |





